# Pasatru

NDC: 61755-012
Generic name: garetosmab-grts
Labeler / Manufacturer: Regeneron Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20260819

FDA application: BLA761508

## Active ingredients

- GARETOSMAB: 300 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61755-012"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61755-012
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0d5cec96-b02b-4f1d-bc66-51e62ce04e3c